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BACKGROUND: Hospital-acquired pneumonia is common after traumatic brain
injury, and might be partly a result of traumatic brain injury-induced adrenal
insufficiency. We tested the efficacy of low-dose hydrocortisone with
fludrocortisone for the prevention of hospital-acquired pneumonia. METHODS: We
did this double-blind, phase 3, placebo-controlled trial in 19 intensive care units in
France. We enrolled patients aged 15-65 years in the first 24 h after severe
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